米国の3D医療画像機器市場規模、シェア、動向分析レポート：機器タイプ別、ハードウェア別、用途別、最終用途別、セグメント予測、2025～2030年

市場規模と動向

米国の3D医療画像機器市場規模は、2024年に36億9,000万米ドルとなり、2025～2030年にかけてCAGR 8.0％で成長すると予測されています。

慢性疾患の有病率の上昇、低侵襲治療への嗜好の高まり、技術の進歩、高齢化人口の増加が、米国の3D医療画像機器産業の成長に寄与する主要因です。心血管障害（CVDs）、がん、神経疾患などの慢性疾患の有病率の増加が、さらに市場成長に寄与しています。米国疾病管理予防センター（CDC）が発表したがんに関するデータによると、2021年には177万7,566人の新規侵襲性がん症例が報告され、年齢調整率は人口10万人当たり445.8人でした。これらの疾患は、早期発見、診断、治療計画のために精密で詳細な画像診断を必要とすることが多いです。MRIやCTスキャンなどの医療用3D画像技術は、ヘルスケア専門家に解剖学的構造や異常の三次元ビューを提供し、より良い意思決定と患者ケアの向上をサポートします。

3D医療画像の進化はその効率を向上させ、ヘルスケア専門家に正確な診断と治療計画のためのより良いツールを提供しています。これらの技術は、解剖学的構造を詳細に視覚化することを可能にし、複雑な病態の検出と管理に役立っています。さらに、画像品質の向上、AIの統合、機器機能の強化など、継続的な進歩が市場の成長をさらに後押ししています。

低侵襲処置への嗜好の高まりが、外科手術やインターベンションの現場における3D画像技術の採用をさらに後押ししています。これらの先進的画像機器は、複雑な解剖学的構造を詳細かつ正確に視覚化し、外科医やインターベンショナルラジオロジストがより効果的に処置を計画できるようにします。3D画像は、課題部位をより正確にナビゲートすることを可能にし、周辺組織へのダメージを最小限に抑えながら、治療の標的を正確に定めることを保証します。このアプローチは、手技の安全性と有効性を高め、早期回復を可能にし、合併症のリスクを低減し、全体的な患者の転帰を改善します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の3D医療画像機器市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 米国の3D医療画像機器市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
• 米国の3D医療画像機器市場：パイプライン分析

第4章 米国の3D医療画像機器市場：機器タイプ別、推定・動向分析

• デバイスタイプセグメントダッシュボード
• 米国の3D医療用画像機器市場：機器タイプ変動分析
• 米国の3D医療用画像機器市場規模と動向分析（機器タイプ別、2018～2030年）
• ハードウェア
• ソフトウェア

第5章 米国の3D医療画像機器市場：ハードウェア別、推定・動向分析

• ハードウェアセグメントダッシュボード
• 米国の3D医療画像機器市場：ハードウェア変動分析
• 米国の3D医療用画像機器市場規模と動向分析（ハードウェア別、2018～2030年）
• X線装置
• CT装置
• 超音波システム
• MRI装置

第6章 米国の3D医療画像機器市場：用途別、推定・動向分析

• 用途セグメントダッシュボード
• 米国の3D医療用画像機器市場：用途変動分析
• 米国の3D医療用画像機器市場規模と動向分析（用途別、2018～2030年）
• 腫瘍学
• 心臓病学
• 整形外科
• 婦人科
• その他

第7章 米国の3D医療画像機器市場：最終用途別、推定・動向分析

• 病院
• 診断画像センター
• その他

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要企業ヒートマップ分析、2024年
• 企業プロファイル
  • Siemens Healthineers AG
  • Esaote SPA
  • Koninklijke Philips NV
  • GE Healthcare
  • CANON MEDICAL SYSTEMS CORPORATION
  • Hitachi High-Tech Corporation
  • Shimadzu Corporation
  • DigiRad Corporation
  • UMG/DEL MEDICAL

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. 3D medical imaging devices market, by device type, 2018 - 2030 (USD Billion)
• Table 3 U.S. 3D medical imaging devices market, by hardware, 2018 - 2030 (USD Billion)
• Table 4 U.S. 3D medical imaging devices market, by application, 2018 - 2030 (USD Billion)
• Table 5 U.S. 3D medical imaging devices market, by end use, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. 3D medical imaging devices market: market outlook
• Fig. 10 U.S. 3D medical imaging devices competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Industry value chain analysis
• Fig. 15 U.S. 3D medical imaging devices market driver impact
• Fig. 16 U.S. 3D medical imaging devices market restraint impact
• Fig. 17 U.S. 3D medical imaging devices market strategic initiatives analysis
• Fig. 18 U.S. 3D medical imaging devices market: Device type movement analysis
• Fig. 19 U.S. 3D medical imaging devices market: Device type outlook and key takeaways
• Fig. 20 Hardware market estimates and forecast, 2018 - 2030
• Fig. 21 Software market estimates and forecast, 2018 - 2030
• Fig. 22 U.S. 3D medical imaging devices Market: Hardware movement Analysis
• Fig. 23 U.S. 3D medical imaging devices market: Hardware outlook and key takeaways
• Fig. 24 X-ray devices market estimates and forecasts, 2018 - 2030
• Fig. 25 CT devices market estimates and forecasts,2018 - 2030
• Fig. 26 Ultrasound systems market estimates and forecasts,2018 - 2030
• Fig. 27 MRI equipment market estimates and forecasts, 2018 - 2030
• Fig. 28 U.S. 3D medical imaging devices market: Application movement analysis
• Fig. 29 U.S. 3D medical imaging devices market: Application outlook and key takeaways
• Fig. 30 Oncology market estimates and forecasts, 2018 - 2030
• Fig. 31 Cardiology market estimates and forecasts, 2018 - 2030
• Fig. 32 Orthopedic market estimates and forecasts, 2018 - 2030
• Fig. 33 Gynecology market estimates and forecasts, 2018 - 2030
• Fig. 34 Others market estimates and forecasts, 2018 - 2030
• Fig. 35 U.S. 3D medical imaging devices market: End Use movement analysis
• Fig. 36 U.S. 3D medical imaging devices market: End Use outlook and key takeaways
• Fig. 37 Hospitals market estimates and forecasts, 2018 - 2030
• Fig. 38 Diagnostic imaging centers market estimates and forecasts, 2018 - 2030
• Fig. 39 Others market estimates and forecasts, 2018 - 2030

Market Size & Trends:

The U.S. 3D medical imaging devices market size was valued at USD 3.69 billion in 2024 and is projected to grow at a CAGR of 8.0% from 2025 to 2030. The rising prevalence of chronic disorders, an increasing preference for minimally invasive procedures, technological advancements, and the growing aging population are the major factors contributing to the growth of the U.S. 3D medical imaging devices industry. The growing prevalence of chronic disorders, such as Cardiovascular Disorders (CVDs), cancer, and neurological conditions, further contributes to market growth. According to data on cancer published by the U.S. Centers for Disease Control and Prevention (CDC), 1,777,566 new invasive cancer cases were reported in 2021, with an age-adjusted rate of 445.8 per 100,000 people. These conditions often require precise and detailed imaging for early detection, diagnosis, and treatment planning. Medical 3D imaging technologies, such as MRI and CT scans, offer healthcare professionals three-dimensional views of anatomical structures and abnormalities, supporting better decision-making and enhancing patient care.

The evolution of 3D medical imaging has improved its efficiency, providing healthcare professionals with better tools for accurate diagnosis and treatment planning. These technologies allow for detailed visualization of anatomical structures, aiding in detecting and managing complex conditions. Furthermore, continuous advancements, such as improved imaging quality, integration of AI, and enhanced device capabilities, further support market growth.

The growing preference for minimally invasive procedures further drives the adoption of 3D imaging technologies in surgical and interventional settings. These advanced imaging devices provide detailed and accurate visualization of complex anatomical structures, enabling surgeons and interventional radiologists to plan procedures more effectively. 3D images enable them to navigate challenging areas more precisely, ensuring that treatment is accurately targeted while minimizing damage to surrounding tissues. This approach helps enhance the safety and efficacy of procedures, enables quicker recovery, reduces risks of complications, and improves overall patient outcomes.

U.S. 3D Medical Imaging Devices Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. 3D medical imaging devices market report based on device type, hardware, application, and end use.

• Device Type Outlook (Revenue, USD Billion, 2018 - 2030)
• Hardware
• Software
• Hardware Outlook (Revenue, USD Billion, 2018 - 2030)
• X-ray Devices
• CT Devices
• Ultrasound Systems
• MRI Equipment
• Application Outlook (Revenue, USD Billion, 2018 - 2030)
• Oncology
• Cardiology
• Orthopedic
• Gynaecology
• Others
• End Use Outlook (Revenue, USD Billion, 2018 - 2030)
• Hospitals
• Diagnostic Imaging Centers
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Device Type
  • 1.2.2. Hardware
  • 1.2.3. Application
  • 1.2.4. End Use
  • 1.2.5. Estimates and Forecasts Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Device Type Outlook
  • 2.2.2. Hardware Outlook
  • 2.2.3. Application Outlook
  • 2.2.4. End Use Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. 3D Medical Imaging Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. U.S. 3D Medical Imaging Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Technological Landscape
    • 3.3.2.3. Economic Landscape
• 3.4. U.S. 3D Medical Imaging Devices Market: Pipeline Analysis

Chapter 4. U.S. 3D Medical Imaging Devices Market: Device Type Estimates & Trend Analysis

• 4.1. Device Type Segment Dashboard
• 4.2. U.S. 3D Medical Imaging Devices Market: Device Type Movement Analysis
• 4.3. U.S. 3D Medical Imaging Devices Market Size & Trend Analysis, by Device Type, 2018 to 2030 (USD Billion)
• 4.4. Hardware
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
• 4.5. Software
  • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)

Chapter 5. U.S. 3D Medical Imaging Devices Market: Hardware Estimates & Trend Analysis

• 5.1. Hardware Segment Dashboard
• 5.2. U.S. 3D Medical Imaging Devices Market: Hardware Movement Analysis
• 5.3. U.S. 3D Medical Imaging Devices Market Size & Trend Analysis, by Hardware, 2018 to 2030 (USD Billion)
• 5.4. X-ray Devices
  • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
• 5.5. CT Devices
  • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
• 5.6. Ultrasound Systems
  • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
• 5.7. MRI Equipment
  • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)

Chapter 6. U.S. 3D Medical Imaging Devices Market: Application Estimates & Trend Analysis

• 6.1. Application Segment Dashboard
• 6.2. U.S. 3D Medical Imaging Devices Market: Application Movement Analysis
• 6.3. U.S. 3D Medical Imaging Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
• 6.4. Oncology
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
• 6.5. Cardiology
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
• 6.6. Orthopedic
  • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
• 6.7. Gynecology
  • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
• 6.8. Others
  • 6.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)

Chapter 7. U.S. 3D Medical Imaging Devices Market: End Use Estimates & Trend Analysis

• 7.1. Hospitals
  • 7.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
• 7.2. Diagnostic Imaging Centers
  • 7.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
• 7.3. Others
  • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key Company Heat Map Analysis, 2024
• 8.4. Company Profiles
  • 8.4.1. Siemens Healthineers AG
    • 8.4.1.1. Company Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Device Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Esaote SPA
    • 8.4.2.1. Company Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Device Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Koninklijke Philips N.V.
    • 8.4.3.1. Company Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Device Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. GE Healthcare
    • 8.4.4.1. Company Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Device Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. CANON MEDICAL SYSTEMS CORPORATION
    • 8.4.5.1. Company Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Device Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Hitachi High-Tech Corporation
    • 8.4.6.1. Company Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Device Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Shimadzu Corporation
    • 8.4.7.1. Company Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Device Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. DigiRad Corporation
    • 8.4.8.1. Company Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Device Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. UMG/DEL MEDICAL
    • 8.4.9.1. Company Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Device Benchmarking
    • 8.4.9.4. Strategic Initiatives